Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-10
DOI
10.1038/srep25743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Translating dosages from animal models to human clinical trials—revisiting body surface area scaling
- (2015) Otis L. Blanchard et al. FASEB JOURNAL
- Novel K+ Channel Targets in Atrial Fibrillation Drug Development—Where Are We?
- (2015) Said El-Haou et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- An Improved Design of Water-Soluble Propofol Prodrugs Characterized by Rapid Onset of Action
- (2014) Bing-Chen Lang et al. ANESTHESIA AND ANALGESIA
- Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation
- (2014) Sana M. Al-Khatib et al. ANNALS OF INTERNAL MEDICINE
- Chemistry-enabled drug delivery (prodrugs): recent progress and challenges
- (2013) Sophie-Dorothee Clas et al. DRUG DISCOVERY TODAY
- Properties and Molecular Determinants of the Natural Flavone Acacetin for Blocking hKv4.3 Channels
- (2013) Hui-Jun Wu et al. PLoS One
- Effects of the natural flavone trimethylapigenin on cardiac potassium currents
- (2012) Yi Liu et al. BIOCHEMICAL PHARMACOLOGY
- Allitridi Inhibits Multiple Cardiac Potassium Channels Expressed in HEK 293 Cells
- (2012) Xiao-Hui Xu et al. PLoS One
- Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain
- (2011) Hui-Jun Wu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dronedarone in High-Risk Permanent Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prodrugs--from Serendipity to Rational Design
- (2011) K. M. Huttunen et al. PHARMACOLOGICAL REVIEWS
- Inhibition of Small-Conductance Ca 2+ -Activated K + Channels Terminates and Protects Against Atrial Fibrillation
- (2010) Jonas Goldin Diness et al. Circulation-Arrhythmia and Electrophysiology
- Effects of a Highly Selective Acetylcholine-Activated K + Channel Blocker on Experimental Atrial Fibrillation
- (2010) Taiichi Machida et al. Circulation-Arrhythmia and Electrophysiology
- Prodrug Design of Phenolic Drugs
- (2010) J.M. Ferriz et al. CURRENT PHARMACEUTICAL DESIGN
- New developments in atrial antiarrhythmic drug therapy
- (2010) Alexander Burashnikov et al. Nature Reviews Cardiology
- Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs
- (2008) Gui-Rong Li et al. CIRCULATION
- Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
- (2008) Joachim R Ehrlich et al. CURRENT OPINION IN CARDIOLOGY
- Prodrugs of Phosphates and Phosphonates
- (2008) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Rhythm Control in Atrial Fibrillation — One Setback after Another
- (2008) Michael E. Cain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More